Skip to main content

Vasoactive Factors and Inflammatory Mediators Produced in Adipose Tissue

  • Chapter
Adipose Tissue and Adipokines in Health and Disease

Part of the book series: Nutrition and Health ((NH))

Abstract

In the search for mechanisms of obesity-mediated vascular pathology, attention has been focused on the role played by adipose tissue, a multifunctional organ involved not only in fat storage but also in the production of numerous hormones, growth factors, and cytokines with pleiotropic features. In the last decade the list of adipose-derived factors shown to be implicated either directly or indirectly in the regulation of vascular homeostasis through effects on blood pressure, inflammation, atherogenesis, coagulation, fibrinolysis, angiogenesis, proliferation, apoptosis, and immunity has increased at a phenomenal pace. By definition, adipocytokines are cytokines produced by adipocytes. Although adipose tissue secretes a wide variety of factors, strictly speaking, not all of them can be contemplated as cytokines. Interleukin-6, tumor necrosis factor-α, leptin, adipsin, resistin, adiponectin, and visfatin fall within the category that satisfies the stricter requirements to be properly classified as adipocytokines. However, the less strict term of adipokines has been coined to include a wider range of factors such as PAI-1, C-reactive protein, monocyte chemoattractant protein-1, serum amyloid A, and vascular endothelial growth factor, among others. Adipokines are known to contribute to the low-grade inflammation state observed in obese patients at the same time as participating in the development of obesity-related comorbidities, such as insulin resistance, metabolic syndrome, and atherogenesis. The molecular mechanisms linking the adiposity-inflammation-immunity cluster are complex. The triad of obesity-insulin resistance-cardiovascular disease is interwoven in a setting of inflammation, endothelial dysfunction and atherosclerosis in which adipokines act as markers of the acute phase reaction at the same time as being directly involved as causative factors in an extensive crosstalk between adipocytes and elements of the stroma vascular fraction. The current knowledge in this field is reviewed with a broad perspective approach.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 209.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eckel RH, Krauss RM. For the AHA Nutrition Committee. Circulation 1998;97:2099–2100.

    CAS  Google Scholar 

  2. Mokdad AH, Ford ES, Bowman BA, et al. JAMA 2003;289:76–79.

    Article  PubMed  Google Scholar 

  3. Gregg EW, Cheng YJ, Cadwell BL, et al. JAMA 2005;293:1868–1874.

    Article  PubMed  CAS  Google Scholar 

  4. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ, et al. Am J Physiol Endocrinol Metab 2001;280: E827–E847.

    PubMed  Google Scholar 

  5. Marette A. Curr Opin Clin Nutr Metab Care 2002;5:377–383.

    Article  PubMed  CAS  Google Scholar 

  6. Blake GJ, Ridker PM. J Intern Med 2002;252:283–294.

    Article  PubMed  CAS  Google Scholar 

  7. Frühbeck G, Salvador J. Nutr Res 2004;24:803–826.

    Article  CAS  Google Scholar 

  8. Frühbeck G. Curr Med Chem—Cardiovasc Hematol Agents 2004;2:197–208.

    Article  PubMed  Google Scholar 

  9. Hauner H. Physiol Behav 2004;83:653–658.

    Article  PubMed  CAS  Google Scholar 

  10. Granger JP. Am J Physiol Reg Integr Comp Physiol 2004;286:R989–R990.

    CAS  Google Scholar 

  11. Fantuzzi G. J Allergy Clin Immunol 2005;1 15:911–919.

    Article  CAS  Google Scholar 

  12. Berg AH, Scherer PE. Circ Res 2005;96:939–949.

    Article  PubMed  CAS  Google Scholar 

  13. Gimeno RE, Klaman LD. Curr Opin Pharmacol 2005;5:122–128.

    Article  PubMed  CAS  Google Scholar 

  14. Juge-Aubry CE, Henrichot E, Meier CA. Best Pract Res Clin Endocrinol Metab 2005;19:547–566.

    Article  PubMed  CAS  Google Scholar 

  15. Kougias P, Chai H, Lin PH, et al. J Surg Res 2005;126:121–129.

    Article  PubMed  CAS  Google Scholar 

  16. Lau DCW, Dhillon B, Yan H, et al. Am J Physiol Heart Circ Physiol 2005;288:H2031–H2041.

    Article  PubMed  CAS  Google Scholar 

  17. Matsuzawa Y. Best Pract Res Clin Endocrinol Metab 2005;19:637–647.

    Article  PubMed  CAS  Google Scholar 

  18. Nawrocki AR, Scherer PE. Drug Discovery Today 2005;10:1219–1230.

    Article  PubMed  CAS  Google Scholar 

  19. Hutley L, Prins JB. Am J Med Sci 2005;330:280–289.

    Article  PubMed  Google Scholar 

  20. Trayhurn P. Acta Physiol Scand 2005;184:285–293.

    Article  PubMed  CAS  Google Scholar 

  21. Schäffler A, Schölmerich J, Büchler C. Nat Clin Pract Gastroenterol Hepatol 2005;2:103–111.

    Article  PubMed  CAS  Google Scholar 

  22. Yu Y-H, Ginsberg HN. Circ Res 2005;96:1042–1052.

    Article  PubMed  CAS  Google Scholar 

  23. Rudin E, Barzilai N. J Immunity Ageing 2005;2:1–3.

    Article  CAS  Google Scholar 

  24. Matsuzawa Y. Nat Clin Pract Cardiovasc Med 2006;3:35–42.

    Article  PubMed  CAS  Google Scholar 

  25. Vague J. Am J Clin Nutr 1956;4:20–34.

    PubMed  CAS  Google Scholar 

  26. Arner P. Biochem Soc Trans 2001;29 Part 2:72–75.

    Article  PubMed  CAS  Google Scholar 

  27. Fernández-Real JM, Ricart W. Endocrine Rev 2003;24:278–301.

    Article  CAS  Google Scholar 

  28. Kaplanski G, Marin V, Montero-Julian F, et al. Trends Immunol 2003;24:25–29.

    Article  PubMed  CAS  Google Scholar 

  29. Chandrasekar B, Mitchell DH, Colston JT, et al. Circulation 1999;99:427–433.

    PubMed  CAS  Google Scholar 

  30. Lyon CJ, Law RE, Hsueh WA. Endocrinology 2003;144:2195–2200.

    Article  PubMed  CAS  Google Scholar 

  31. Fried SK, Bunkin DA, Greenberg AS. J Clin Endocrinol Metab 1998;83:847–850.

    Article  PubMed  CAS  Google Scholar 

  32. Correia ML, Haynes WG. Curr Opin Nephrol Hypertens 2004;13:215–223.

    Article  PubMed  Google Scholar 

  33. Frühbeck G. Diabetes 1999;48:903–908.

    Article  PubMed  Google Scholar 

  34. Frühbeck G. Biochem J 2006;393:7–20.

    Article  PubMed  CAS  Google Scholar 

  35. Fortuño A, Rodríguez A, Gómez-Ambrosi J, et al. Endocrinology 2002;143:3555–3560.

    Article  PubMed  CAS  Google Scholar 

  36. Fantuzzi G, Faggioni R. J Leukoc Biol 2000;68:437–446.

    PubMed  CAS  Google Scholar 

  37. La Cava A, Matarese G. Nat Rev Immunol 2004;4:371–379.

    Article  PubMed  CAS  Google Scholar 

  38. La Cava A, Alviggi C, Matarese G. J Mol Med 2004;82:4–11.

    Article  PubMed  CAS  Google Scholar 

  39. Maslowska M, Vu H, Phelis S, et al. Eur J Clin Invest 1999;29:679–686.

    Article  PubMed  CAS  Google Scholar 

  40. Steppan CM, Lazar MA. J Intern Med 2004;255:439–447.

    Article  PubMed  CAS  Google Scholar 

  41. Koerner A, Kratzsch J, Kiess W. Best Pract Res Clin Endocrinol Metab 2005;19:525–546.

    Article  PubMed  CAS  Google Scholar 

  42. Gómez-Ambrosi J, Frühbeck G. Ann Int Med 2001;135:306–307.

    PubMed  Google Scholar 

  43. Lehrke M, Reilly MP, Millington SC, et al. PloS Medicine 2004;1:161–168.

    Article  CAS  Google Scholar 

  44. Verma S, Li SH, Wang CH, et al. Circulation 2003;108:736–740.

    Article  PubMed  CAS  Google Scholar 

  45. Kawanami D, Maemura K, Takeda N, et al. Biochem Biophys Res Commun 2004;314:415–419.

    Article  PubMed  CAS  Google Scholar 

  46. Yamauchi T, Kamon J, Ito Y, et al. Nature 2003;423:762–769.

    Article  PubMed  CAS  Google Scholar 

  47. Kadowaki T, Yamauchi T. Endocrine Rev 2005;26:439–451.

    Article  CAS  Google Scholar 

  48. Ouchi N, Kihara S, Arita Y, et al. Circulation 2000;102:1296–1301.

    PubMed  CAS  Google Scholar 

  49. Xydakis AM, Case CC, Jones PH, et al. J Clin Endocrinol Metab 2004;89:2697–2703.

    Article  PubMed  CAS  Google Scholar 

  50. Pischon T, Girman CJ, Hotamisligil GS, et al. JAMA 2004;291:1730–1737.

    Article  PubMed  CAS  Google Scholar 

  51. Wellen KE, Hotamisligil GS. J Clin Invest 2003;1 12:1785–1788.

    Article  CAS  Google Scholar 

  52. Fukuhara A, Matsuda M, Nishizawa M, et al. Science 2005;307:426–430.

    Article  PubMed  CAS  Google Scholar 

  53. Sethi JK, Vidal-Puig A. Trends Mol Med 2005;11:344–347.

    Article  PubMed  CAS  Google Scholar 

  54. Berndt J, Kloting N, Kralisch S, et al. Diabetes 2005;54:2911–2916.

    Article  PubMed  CAS  Google Scholar 

  55. Kralisch S, Klein J, Lossner U, et al. Am J Physiol Endocrinol Metab 2005;289:E586–E590.

    Article  PubMed  CAS  Google Scholar 

  56. Chen M-P, Chung F-M, Chang D-M, et al. J Clin Endocrinol Metab 2006;91:295–299.

    Article  PubMed  CAS  Google Scholar 

  57. Arner P. J Clin Endocrinol Metab 2006;91:28–30.

    Article  PubMed  CAS  Google Scholar 

  58. Skurk T, Havner H. Int J Obes Relat Metab Disord 2004;28:1357–1364.

    Article  PubMed  CAS  Google Scholar 

  59. Alessi MC, Peiretti F, Morange P, et al. Diabetes 1997;46:860–867.

    Article  PubMed  CAS  Google Scholar 

  60. Yudkin JS, Stehouwer CD, Emeis JJ, et al. Arterioscler Thromb Vasc Biol 1999;19:972–978.

    PubMed  CAS  Google Scholar 

  61. Ouchi N, Kihara S, Nagai R, et al. Circulation 2003;107:671–674.

    Article  PubMed  CAS  Google Scholar 

  62. Verma S, Badiwala MV, Weisel RD, et al. J Thorac Cardiovasc Surg 2003;126:1886–1891.

    Article  PubMed  CAS  Google Scholar 

  63. Verma S, Kuliszewski MA, Li SH, et al. Circulation 2004;109:2058–2067.

    Article  PubMed  CAS  Google Scholar 

  64. Labarrere CA, Zaloga GP. Am J Med 2004;117:499–507.

    Article  PubMed  CAS  Google Scholar 

  65. Linton MF, Fazio S. Int J Obes Relat Metab Disord 2003;27(Suppl 3):S35–S40.

    Article  PubMed  CAS  Google Scholar 

  66. Charo IF, Taubman MB. Circ Res 2004;95:858–866.

    Article  PubMed  CAS  Google Scholar 

  67. Malavazos AE, Cereda E, Morricone L, et al. Eur J Endocrinol 2005;153:871–877.

    Article  PubMed  CAS  Google Scholar 

  68. Martinovic I, Abegunewardene N, Seul M, et al. Circ J 2005;69:1484–1489.

    Article  PubMed  CAS  Google Scholar 

  69. Clément K, Viguerie N, Poitou C, et al. FASEB J 2004;18:1657–1669.

    Article  PubMed  CAS  Google Scholar 

  70. Miyazawa-Hoshimoto S, Takahashi K, Bujo H, et al. Diabetologia 2003;46:1483–1488.

    Article  PubMed  CAS  Google Scholar 

  71. Gómez-Ambrosi J, Catalán V, Diez-Caballero A, et al. FASEB J 2004;18:215–218.

    PubMed  Google Scholar 

  72. Verma S, Anderson TJ. Circulation 2002;105:546–549.

    Article  PubMed  CAS  Google Scholar 

  73. Libby P, Ridker PM, Maseri A. Circulation 2002;105:1135–1143.

    Article  PubMed  CAS  Google Scholar 

  74. Shoelson SE, Lee J, Yuan M. Int J Obes Relat Metab Disord 2003;27(Suppl 3):S49–S52.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Frühbeck, G. (2007). Vasoactive Factors and Inflammatory Mediators Produced in Adipose Tissue. In: Fantuzzi, G., Mazzone, T. (eds) Adipose Tissue and Adipokines in Health and Disease. Nutrition and Health. Humana Press. https://doi.org/10.1007/978-1-59745-370-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-370-7_5

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-721-1

  • Online ISBN: 978-1-59745-370-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics